CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Luminex has received FDA clearance for its xTAG gastrointestinal pathogen panel (GPP), which is a comprehensive molecular diagnostic assay that tests for greater than 90 percent of bacterial, viral, and parasitic causes of infectious gastroenteritis.
The xTAG GPP nucleic acid-based amplification assay simultaneously tests for 11 common gastroenteritis-causing viruses, bacteria, and parasites. The panel includes Campylobacter, Clostridium difficile, toxin A/B, Escherichia coli O157, enterotoxigenic E. coli (ETEC) LT/ST, shiga-like toxin-producing E. coli stx1/ stx2, Salmonella, Shigella, rotavirus A, norovirus GI/GII, Giardia lamblia, and Cryptosporidium.
xTAG GPP delivers multiple results within five hours. The assay is cleared on Luminex’s 100/200 system.
Luminex, 512-219-8020